scispace - formally typeset
S

Sally Hunter

Researcher at University of Cambridge

Publications -  36
Citations -  1620

Sally Hunter is an academic researcher from University of Cambridge. The author has contributed to research in topics: Population & Dementia. The author has an hindex of 14, co-authored 32 publications receiving 1087 citations. Previous affiliations of Sally Hunter include University of East Anglia.

Papers
More filters
Journal ArticleDOI

Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study

TL;DR: Multivariable analysis identified associations between dementia during life and entorhinal cortex neuritic plaques, hippocampal diffuse plaque, neocortical neurofibrillary tangles, white matter pallor, Lewy bodies, and hippocampal atrophy, which were consistent in those with clinical Alzheimer's disease.
Journal ArticleDOI

The neuropathological profile of mild cognitive impairment (MCI): a systematic review

TL;DR: It is clear that mild cognitive impairment is neuropathologically complex and cannot be understood within a single framework, and standardization of the definition of MCI and reporting of pathology would greatly assist in building an integrated picture of the clinical and neuropathological profile ofMCI.
Journal ArticleDOI

Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

TL;DR: The ACH, PSH and AMA in relation to levels of APP proteolytic fragments reported from AD-associated mutations in APP are reviewed and the confounding effects of sequence homology, complexity of competing cleavages and antibody cross reactivities all illustrate limitations in the understanding of the roles these fragments and the APP proteologic system as a whole in normal aging and disease play.
Journal ArticleDOI

The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.

TL;DR: The senescence hypothesis of AD progression is presented, suggesting that factors associated with AD can be seen as partial stressors within the matrix of signalling pathways that underlie cell survival and function.